| Nov 8 |
Earnings Release: Here's Why Analysts Cut Their SOPHiA GENETICS SA (NASDAQ:SOPH) Price Target To US$6.00
|
| Nov 4 |
SOPHiA GENETICS SA (SOPH): A Bull Case Theory
|
| Nov 1 |
Fulgent Genetics (FLGT) Surges 5.8%: Is This an Indication of Further Gains?
|
| Oct 22 |
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024
|
| Sep 12 |
SOPHiA GENETICS Announces Poster Presentations at ESMO 2024
|
| Sep 12 |
SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024
|
| Sep 11 |
Sophia Genetics and AstraZeneca collaborate to expand liquid biopsy test rollout
|
| Sep 10 |
SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
|
| Aug 28 |
SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference
|
| Aug 9 |
What Makes SOPHiA GENETICS (SOPH) a New Buy Stock
|
